Unique Wealth Strategies LLC Purchases Shares of 1,762 UnitedHealth Group Incorporated (NYSE:UNH)

Unique Wealth Strategies LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,762 shares of the healthcare conglomerate’s stock, valued at approximately $928,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Richelieu Gestion SA purchased a new position in UnitedHealth Group in the 4th quarter worth $26,000. Robbins Farley bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $25,000. CGC Financial Services LLC grew its position in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC boosted its stake in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the period. Finally, LFA Lugano Financial Advisors SA increased its stake in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 0.3 %

UnitedHealth Group stock traded up $1.49 during mid-day trading on Friday, reaching $495.35. The stock had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The company has a market capitalization of $455.76 billion, a price-to-earnings ratio of 30.28, a PEG ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a 50-day moving average price of $485.84 and a two-hundred day moving average price of $514.21.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the prior year, the firm posted $6.26 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on UNH shares. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. TD Cowen cut their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Truist Financial reaffirmed a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Piper Sandler lifted their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.